Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

1329738

registered interest
date	04/06/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Streptococcus: Clinical Trials
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to encourage hospitals to participate in the GBS3 clinical trial investigating Group B Strep infection.
tabling member constituency	York Outer
tabling member printed	Julian Sturdy
uin	10367
answer	answer is ministerial correction date of answer 16/06/2021 answer text <p>The Department is working with the National Institute for Health Research (NIHR), including the NIHR’s Clinical Research Network, NHS England and NHS Improvement and the GBS3 team to encourage trusts to take part in this important trial and to mitigate any individual challenges that might prevent their participation.</p> answering member constituency Mid Bedfordshire answering member printed Ms Nadine Dorries question first answered 16/06/2021 09:03:01 answering member 1481 label Biography information for Ms Nadine Dorries
tabling member	4079 label Biography information for Julian Sturdy

1329862

registered interest
date	04/06/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to (a) assess the effectiveness of covid-19 vaccines for people with blood cancer and (b) establish a testing programme to clarify whether people with blood cancer retain compromised immune systems against covid-19 even after vaccination.
tabling member constituency	York Outer
tabling member printed	Julian Sturdy
uin	10368
answer	answer is ministerial correction date of answer 29/06/2021 answer text <p>All of the currently authorised COVID-19 vaccines are suitable for use in immunocompromised individuals, including those with blood cancer. The clinical studies for these vaccines excluded immunocompromised subjects and therefore no data is currently available regarding the use of these vaccines when used at the same time as immunosuppressant medicines or the immune response in those on such medications. However, data is being collected on use of the vaccines in immunocompromised subjects and the Medicines and Healthcare products Regulatory Agency will assess this data as soon as it become available. Public Health England is also monitoring the impact of COVID-19 vaccines on a broad range of outcomes including symptomatic disease, infection and hospitalisations as set out in the vaccine surveillance strategy, including protection in different clinical risk groups.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 29/06/2021 15:30:34 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4079 label Biography information for Julian Sturdy